Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JOHN W. who wrote (1106)	7/31/1997 10:23:00 PM
From: Peter Church	of 6136

John, you have been nothing but right so far. Congratulations! It is too bad that there wasn't time to discuss Thymitaq during the call. It's really been in the background and overshadowed. I would like to know where the trials stand, if you have any insight into their progress. We still have to see $140. After today, the shorts should be running for cover and 120 looks in the bag, (after we get through 101). We have more than $250,000,000 * 60% // 14,000,000 // 2 = $5.4 / share next year plus Europe and Japan plus future drugs. With a PE of 30, shares at $160!

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next